| Class Number |
Class Name |
No. of Patents |
| 424/77 |
Adhesive trapping compositions |
42 |
| 424/DIG.1 |
Aerosol hair preparation |
292 |
| 424/65 |
Anti-perspirants or perspiration deodorants |
985 |
| 424/68 |
Aluminum compound containing |
543 |
| 424/67 |
Zinc compound containing |
253 |
| 424/66 |
Zirconium compound containing |
451 |
| 424/803 |
Antibody or antigen-binding fragment thereof that binds gram-negative bacteria |
11 |
| 424/802 |
Antibody or antigen-binding fragment thereof that binds gram-positive bacteria |
7 |
| 424/800 |
Antibody or fragment thereof whose amino acid sequence is disclosed in whole or in part |
22 |
| 424/184.1 |
Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) |
2453 |
| 424/275.1 |
Allergen or component thereof (e.g., ragweed pollen, etc.) |
192 |
| 424/276.1 |
Characterized by molecular weight |
46 |
| 424/185.1 |
Amino acid sequence disclosed in whole or in part; or conjugate, complex, or fusion protein or fusion polypeptide including the same |
1761 |
| 424/190.1 |
Disclosed amino acid sequence derived from bacterium (e.g., mycoplasma, anaplasma, etc.) |
578 |
| 424/191.1 |
Disclosed amino acid sequence derived from parasitic organism (e.g., dirofilaria, eimeria, trichinella, etc.) |
189 |
| 424/186.1 |
Disclosed amino acid sequence derived from virus |
440 |
| 424/189.1 |
Hepatitis virus |
218 |
| 424/187.1 |
Retroviridae (e.g., feline leukemia, etc.) |
86 |
| 424/188.1 |
Immunodeficiency virus (e.g., hiv, etc.) |
383 |
| 424/234.1 |
Bacterium or component thereof or substance produced by said bacterium (e.g., legionella, borrelia, anaplasma, shigella, etc.) |
1018 |
| 424/246.1 |
Bacillus |
67 |
| 424/253.1 |
Bordetella (e.g., bordetella bronchiseptica, etc.) |
68 |
| 424/254.1 |
Bordetella pertussis |
95 |
| 424/252.1 |
Brucella (e.g., brucella abortus, brucella canis, etc.) |
30 |
| 424/263.1 |
Chlamydia (e.g., chlamydia trachomatis, etc.) |
77 |
| 424/247.1 |
Clostridium (e.g., clostridium tetani, clostridium difficile, clostridium perfringens, clostridium botulinum, clostridium chauvoei, etc.) |
92 |
| 424/245.1 |
Corynebacterium (e.g., corynebacterium diphtheriae, etc.) |
47 |
| 424/257.1 |
Escherichia (e.g., escherichia coli, etc.) |
146 |
| 424/256.1 |
Hemophilus (e.g., hemophilus influenzae, hemophilus gallinarum, hemophilus pleuropnemoniae, etc.) |
196 |
| 424/259.1 |
Klebsiella (e.g., klebsiella pneumoniae, etc.) |
29 |
| 424/251.1 |
Moraxella (e.g., moraxella bovis, etc.) |
55 |
| 424/248.1 |
Mycobacterium (e.g., mycobacterium tuberculosis, calmette-guerin bacillus (i.e., bcg), etc.) |
228 |
| 424/264.1 |
Mycoplasma |
45 |
| 424/249.1 |
Neisseria (e.g., neisseria gonorrhoeae, etc.) |
91 |
| 424/250.1 |
Neisseria meningitidis |
118 |
| 424/255.1 |
Pasteurella (e.g., pasteurella multocida, pasteurella hemolytica, etc.) |
87 |
| 424/242.1 |
Pilus, fimbria, or adhesin |
81 |
| 424/260.1 |
Pseudomonas (e.g., pseudomonas aeruginosa, etc.) |
87 |
| 424/258.1 |
Salmonella (e.g., salmonella typhimurium, etc.) |
141 |
| 424/243.1 |
Staphylococcus (e.g., staphylococcus aureus, etc.) |
106 |
| 424/244.1 |
Streptococcus (e.g., group b streptococcus, pneumococcus or streptococcus pneumoniae, etc.) |
295 |
| 424/236.1 |
Toxin or toxoid, except endotoxin (e.g., exotoxin, enterotoxin, etc.) |
321 |
| 424/240.1 |
Bordetella (e.g., bordetella pertussis, etc.) |
114 |
| 424/239.1 |
Clostridium (e.g., clostridium tetani, etc.) |
167 |
| 424/238.1 |
Corynebacterium (e.g., corynebacterium diphtheriae, etc.) |
45 |
| 424/241.1 |
Escherichia (e.g., escherichia coli, etc.) |
123 |
| 424/237.1 |
Staphylococcus or streptococcus |
115 |
| 424/235.1 |
Transposon mutant or deletion mutant bacterium (e.g., produced by transposon mutagenesis, etc.) |
93 |
| 424/262.1 |
Treponema (e.g., treponema hyodysenteriae, treponema pallidum, etc.) |
42 |
| 424/261.1 |
Vibrio (e.g., vibrio cholera, etc.) |
81 |
| 424/277.1 |
Cancer cell or component thereof |
382 |
| 424/203.1 |
Combination of antigens from multiple bacterial species (e.g., multivalent bacterial vaccine, etc.) |
207 |
| 424/202.1 |
Combination of antigens from multiple viral species (e.g., multivalent viral vaccine, etc.) |
203 |
| 424/201.1 |
Combination of viral and bacterial antigens (e.g., multivalent viral and bacterial vaccine, etc.) |
133 |
| 424/193.1 |
Conjugate or complex |
840 |
| 424/197.11 |
Conjugate or complex includes bacterium or component thereof or substance produced by said bacterium |
371 |
| 424/195.11 |
Conjugate or complex includes hormone or other secreted growth regulatory factor, differentiation factor, intercellular mediator, or fragment thereof |
218 |
| 424/196.11 |
Conjugate or complex includes virus or componenet thereof |
226 |
| 424/194.1 |
Conjugated via claimed linking group, bond, or coupling agent |
360 |
| 424/274.1 |
Fungus, except allergen, or component thereof or substance produced by said fungus (e.g., trichophyton, etc.) |
96 |
| 424/192.1 |
Fusion protein or fusion polypeptide (i.e., expression product of gene fusion) |
950 |
| 424/198.1 |
Hormone or other secreted growth regulatory factor, differentiation factor, intercellular mediator, neurotransmitter, or fragment thereof |
462 |
| 424/265.1 |
Parasitic organism or component thereof or substance produced by said parasitic organism (e.g., schistosoma, dirofilaria, trichinella, fasciola, ancylostoma, ascaris, etc.) |
246 |
| 424/266.1 |
Component characterized by molecular weight |
72 |
| 424/267.1 |
Eimeria |
36 |
| 424/268.1 |
Plasmodium |
77 |
| 424/269.1 |
Parasitic protozoan (e.g., trypanosoma, trichomonas, leishmania, entamoeba, etc.) |
155 |
| 424/270.1 |
Babesia |
26 |
| 424/271.1 |
Eimeria |
50 |
| 424/272.1 |
Plasmodium |
87 |
| 424/273.1 |
Toxoplasma |
31 |
| 424/200.1 |
Recombinant or stably-transformed bacterium encoding one or more heterologous proteins or fragments thereof |
244 |
| 424/199.1 |
Recombinant virus encoding one or more heterologous proteins or fragments thereof |
579 |
| 424/204.1 |
Virus or component thereof |
985 |
| 424/233.1 |
Adenoviridae, adeno-like virus, or parvoviridae (e.g., adenovirus, canine parvovirus, mink enteritis virus, hemorrhagic enteritis virus, feline panleukopenia virus, egg drop syndrome virus, etc.) |
145 |
| 424/216.1 |
Calciviridae or picornaviridae, except hepatitis a virus (e.g., foot-and- mouth disease virus (fmdv), coxsackievirus, echovirus, avian encephalomyelitis virus, mengovirus, etc.) |
64 |
| 424/217.1 |
Poliovirus |
64 |
| 424/221.1 |
Coronaviridae (e.g., neonatal calf diarrhea virus, feline infectious peritonitis virus, canine coronavirus, etc.) |
52 |
| 424/222.1 |
Infectious bronchitis virus (ibv) |
32 |
| 424/223.1 |
Transmissible gastroenteritis virus (i.e., tge) |
15 |
| 424/225.1 |
Hepatitis virus (e.g., infectious canine hepatitis virus, duck hepatitis virus, mouse hepatitis virus, etc.) |
60 |
| 424/226.1 |
Hepatitis a virus |
73 |
| 424/227.1 |
Hepatitis b virus (e.g., hepatitis b surface antigen (hbsag), pre-s region, hepatitis b core antigen (hbcag), hepatitis b e-antigen, dane particle, etc.) |
194 |
| 424/228.1 |
Non-a, non-b hepatitis virus or hepatitis c virus |
154 |
| 424/229.1 |
Herpetoviridae (e.g., herpesvirus, marek`s disease virus, laryngotracheitis virus, infectious bovine rhinotracheitis virus (ibr), infectious pustular vulvovaginitis virus, bovine herpes virus type 1, aujeszky`s disease virus, feline rhinotracheitis virus, feline herpes virus, etc.) |
296 |
| 424/230.1 |
Cytomegalovirus, varicella or herpes zoster virus, or epstein-barr virus |
150 |
| 424/231.1 |
Herpes simplex virus (e.g., hsv-1, hsv-2, etc.) |
144 |
| 424/209.1 |
Orthomyxoviridae (e.g., influenza virus, fowl plague virus, etc.) |
179 |
| 424/210.1 |
Subunit vaccine containing hemagglutinin or neuraminidase |
69 |
| 424/211.1 |
Paramyxoviridae (e.g., parainfluenza virus, respiratory syncytial virus, rinderpest virus, sendai virus, canine tracheobronchitis virus, turkey rhinotracheitis virus, etc.) |
178 |
| 424/213.1 |
Canine distemper virus |
24 |
| 424/212.1 |
Measles virus or mumps virus |
73 |
| 424/214.1 |
Newcastle disease virus |
61 |
| 424/232.1 |
Poxviridae (e.g., smallpox virus, avian pox virus, fowlpox virus, rabbit myxoma virus, vaccinia virus, etc.) |
137 |
| 424/205.1 |
Reassortant or deletion mutant virus |
176 |
| 424/206.1 |
Influenza virus |
101 |
| 424/215.1 |
Reoviridae (e.g., rotavirus, reovirus, orbivirus, avian proventriculitis virus, bluetongue virus, colorado tick fever virus, etc.) |
98 |
| 424/207.1 |
Retroviridae (e.g., feline leukemia virus, bovine leukemia virus, avian leukosis virus, equine infectious anemia virus, rous sarcoma virus, htlv-i, etc.) |
147 |
| 424/208.1 |
Immunodeficiency virus (e.g., hiv, etc.) |
497 |
| 424/224.1 |
Rhabdoviridae (e.g., rabies virus, vesicular stomatitis virus, etc.) |
91 |
| 424/218.1 |
Togaviridae or flaviviridae, except hepatitis c virus (e.g., yellow fever virus, bovine viral diarrhea virus, dengue virus, equine viral arteritis virus, equine encephalitis virus, japanese b encephalitis virus, sindbis virus, flavivirus, etc.) |
170 |
| 424/220.1 |
Hog cholera virus |
13 |
| 424/219.1 |
Rubella virus |
33 |
| 424/826 |
Bacterial vaccine for avian species (e.g., poultry or other birds, etc.) |
33 |
| 424/823 |
Bacterial vaccine for bovine species (e.g., cattle, etc.) |
55 |
| 424/828 |
Bacterial vaccine for canidae or mustelidae (e.g., dogs, foxes, minks, etc.) |
17 |
| 424/829 |
Bacterial vaccine for equine species (e.g., horses, etc.) |
15 |
| 424/827 |
Bacterial vaccine for fish |
17 |
| 424/824 |
Bacterial vaccine for ovine species (e.g., sheep, etc.) |
26 |
| 424/825 |
Bacterial vaccine for porcine species (e.g., swine, etc.) |
66 |
| 424/84 |
Baits, attractants, or lures (non-food) |
582 |
| 424/62 |
Bleach for live hair or skin (e.g., peroxides, etc.) |
398 |
| 424/DIG.13 |
Burn treatment |
170 |
| 424/DIG.6 |
Chelate |
72 |
| 424/48 |
Chewing gum type |
467 |
| 424/40 |
Combustible or chemically reactive to produce a smoke, mist or aerosol |
118 |
| 424/41 |
Elemental sulfur containing |
12 |
| 424/42 |
Nitrate containing |
15 |
| 424/178.1 |
Conjugate or complex of monoclonal or polyclonal antibody, immunoglobulin, or fragment thereof with nonimmunoglobulin material |
717 |
| 424/182.1 |
Conjugate includes potentiator; or composition comprising conjugate includes potentiator |
79 |
| 424/183.1 |
Conjugated to proteinaceous toxin or fragment thereof (e.g., conjugated to diphtheria toxin, pseudomonas exotoxin, ricin, gelonin, abrin, etc.) |
303 |
| 424/179.1 |
Conjugated via claimed linking group, bond, chelating agent, or coupling agent (e.g., conjugated to proteinaceous toxin via claimed linking group, bond, coupling agent, etc.) |
263 |
| 424/180.1 |
Conjugate includes potentiator or composition comprising conjugate includes potentiator |
57 |
| 424/181.1 |
Conjugated to nonproteinaceous bioaffecting compound (e.g., conjugated to cancer-treating drug, etc.) |
246 |
| | Cross reference art collection relating to subclasses 9.1 through 10.4 | |
| 424/DIG.4 |
Dandruff |
122 |
| 424/DIG.16 |
Dendrimers and dendritic polymers |
89 |
| 424/49 |
Dentifrices (includes mouth wash) |
2125 |
| 424/54 |
Ammonia, amine, or derivative thereof (e.g., urea, etc.) |
562 |
| 424/50 |
Ferment containing (e.g., enzymes, bacteria, etc.) |
180 |
| 424/52 |
Fluorine or fluorine compound containing |
918 |
| 424/55 |
Hydroxy carboxylic acid or derivative thereof (e.g., methyl salicylate, etc.) |
171 |
| 424/51 |
Iodine or iodine compound containing |
40 |
| 424/56 |
Organic sulfate or sulfonate containing |
126 |
| 424/53 |
Oxygen or chlorine releasing compound containing |
435 |
| 424/57 |
Phosphate compound containing |
521 |
| 424/58 |
Plant extract of undetermined constitution |
275 |
| 424/76.1 |
Deodorants (nonbody) |
281 |
| 424/76.2 |
Deodorizing substance is evaporable sublimable or gas (e.g., deodorization of air, aerosol spray compositions, etc.) |
142 |
| 424/76.21 |
For chemical reaction with odor producing material or gas evolving composition |
94 |
| 424/76.3 |
From a gel or solid matrix (e.g., retarded vaporization compositions, etc.) |
103 |
| 424/76.4 |
With odor masking substances (e.g., perfumes, etc.) |
255 |
| 424/76.5 |
For application to waste materials, solid or liquid refuse or sewage |
96 |
| 424/76.6 |
Waste includes fecal material or urine (e.g., feed lot or cage waste, pet litter, etc.) |
126 |
| 424/76.7 |
For toilet or urinal (e.g., recirculating toilet fluid, etc.) |
53 |
| 424/76.8 |
With bio-affecting material (i.e., biocide or biostat) |
150 |
| 424/76.9 |
Inorganic only or containing plant or animal extract |
66 |
| 424/78.01 |
Digestive system regulator containing solid synthetic organic polymer as designated organic active ingredient (doai) (e.g., anti-diarrhetic, anticonstipation, appetite suppressant, laxative, etc.): |
117 |
| 424/43 |
Effervescent or pressurized fluid containing |
411 |
| 424/44 |
Gas produced in situ by chemical reaction |
226 |
| 424/45 |
Organic pressurized fluid |
1374 |
| 424/46 |
Powder or dust containing |
562 |
| 424/47 |
Topical live body grooming or adorning aid (e.g., hair spray, antiperspirant, etc.) |
1062 |
| 424/75 |
Embalming or undertaking compositions |
45 |
| 424/94.1 |
Enzyme or coenzyme containing |
682 |
| 424/94.6 |
Hydrolases (3. ) (e.g., urease, lipase, asparaginase, muramidase, etc.) |
404 |
| 424/94.61 |
Acting on glycosyl compound (3.2) (e.g., glycosidases lysozyme, nucleosidases, cellulase, etc.) |
292 |
| 424/94.62 |
Hyaluronidase or mucinase (3.2.1.35, 3.2.1.36) |
65 |
| 424/94.63 |
Acting on peptide bonds (3.4) (e.g., urokinease, etc.) |
402 |
| 424/94.66 |
Acid proteinases (3.4.23) (e.g., pepsin, renin, chymosin, etc.) |
66 |
| 424/94.67 |
Metalloproteinases (3.4.24) (e.g., collagenase, snake venom zinc proteinase, etc.) |
100 |
| 424/94.64 |
Serene proteinases (3.4.21) (e.g., trypsin, chymotrypsin, plasmin, thrombin, elastase, kallikrein, fibrinolysin, streptokinease, etc.) |
615 |
| 424/94.65 |
Sh-proteinases (3.4.22) (e.g., papain, chymopapain, bromelains, ficin, etc.) |
103 |
| 424/94.2 |
Multienzyme complexes or mixtures of enzymes |
193 |
| 424/94.21 |
Pancreatin |
29 |
| 424/94.4 |
Oxidoreductases (1. ) (e.g., catalase, dehydrogenases, reductases, etc.) |
321 |
| 424/94.3 |
Stabilized enzymes or enzymes complexed with nonenzyme (e.g., liposomes, etc.) |
303 |
| 424/94.5 |
Transferases (2. ), lyase (4.), isomerase (5.), ligase (6.) |
247 |
| 424/780 |
Extract or material containing or obtained from a micro-organism as active ingredient (e.g., bacteria, protozoa, etc.) |
58 |
| 424/195.15 |
Extract or material containing or obtained from a multicellular fungus as active ingredient (e.g., mushroom, filamentous fungus, fungal spore, hyphae, mycelium, etc.) |
150 |
| 424/195.16 |
Extract or material containing or obtained from a unicellular fungus as active ingredient (e.g., yeast, etc.) |
107 |
| 424/195.17 |
Extract or material containing or obtained from an alga as active ingredient (e.g., chlorella, seaweed, laver, kelp, etc.) |
146 |
| 424/520 |
Extract, body fluid, or cellular material of undetermined constitution derived from animal is active ingredient |
389 |
| 424/528 |
Bile, bile acid, bile salt, amniotic fluid, or ascitic fluid |
22 |
| 424/529 |
Blood |
327 |
| 424/533 |
Erythrocyte |
131 |
| 424/534 |
Leucocyte |
157 |
| 424/530 |
Plasma |
247 |
| 424/532 |
Platelet |
135 |
| 424/531 |
Serum |
123 |
| 424/537 |
Body fluid or exudate or transudate other than snake venom, feces, urine, or semen (e.g., lymph, saliva, honey, royal jelly, digestive juice, etc.) |
94 |
| 424/569 |
Cardiovascular system, other than umbilical artery or vein (e.g., blood vessel, heart, cardiac muscle, etc.) |
51 |
| 424/538 |
Derived from arthropod (e.g., insect, spider, crustacea, etc.) |
85 |
| 424/539 |
Bee |
49 |
| 424/541 |
Cantharide |
0 |
| 424/547 |
Derived from mollusk |
50 |
| 424/548 |
Derived from musculoskeletal system, other than cardiac muscle (e.g., cartilage, muscle, etc.) |
122 |
| 424/549 |
Skeleton (e.g., bone, teeth, etc.) |
116 |
| 424/542 |
Derived from snake (e.g, venom, etc.) |
39 |
| 424/550 |
Digestive system (e.g., salivary gland, etc.) |
37 |
| 424/551 |
Gastrointestinal system (e.g., intestine, stomach, gall bladder, etc.) |
90 |
| 424/553 |
Liver |
46 |
| 424/554 |
Fish liver oil or solidified form thereof |
16 |
| 424/555 |
Cod liver oil or solidified form thereof |
11 |
| 424/556 |
Pancreas |
29 |
| 424/581 |
Egg enclosed in shell or a part thereof (e.g., eggshell, egg yolk, etc.) |
67 |
| 424/582 |
Embryonic structure (e.g., embryo or fetus, etc.) |
46 |
| 424/583 |
Placenta or umbilical cord |
64 |
| 424/562 |
Endocrine system, other than the thymus gland (e.g., parathyroid gland, etc.) |
34 |
| 424/563 |
Adrenal gland |
14 |
| 424/565 |
Pituitary gland |
13 |
| 424/568 |
Thyroid gland |
21 |
| 424/577 |
Hemic or immune system (e.g., hematopoietic system, bone marrow cells, etc.) |
101 |
| 424/578 |
Lymphoid tissue (e.g., adenoid, lymph node, etc.) |
43 |
| 424/579 |
Spleen |
29 |
| 424/580 |
Thymus gland |
39 |
| 424/535 |
Milk or colostrum (e.g., butter, whey, etc.) |
149 |
| 424/570 |
Nervous system (e.g., brain, nerve, etc.) |
89 |
| 424/557 |
Respiratory system (e.g., lung, etc.) |
37 |
| 424/571 |
Sense organ (e.g., eye, taste bud, etc.) |
31 |
| 424/522 |
Separated animal oil or solidified form thereof derived from animal flesh and other than from liver or dairy type |
72 |
| 424/523 |
Fish oil or solidified form thereof |
76 |
| 424/526 |
Lard, rind, or tallow |
9 |
| 424/525 |
Skunk, musk, or mink oil or solidified form thereof |
7 |
| 424/524 |
Whale or porpoise oil or solidified form thereof |
7 |
| 424/572 |
Tissue, other than lymphoid tissue (e.g., connective, etc.) |
101 |
| 424/574 |
Adipose or epithelium |
83 |
| 424/573 |
Neoplastic, tumor, or cancer |
67 |
| 424/558 |
Urogenital system (e.g., kidney, etc.) |
38 |
| 424/559 |
Genitalia (e.g., ovary, uterus, prostate, testis, etc.) |
35 |
| 424/561 |
Germ cell (e.g., ovum, spermatozoa, etc.) |
65 |
| 424/543 |
Waste or feces (e.g., slaughterhouse offal, chicken feet, horn, hair, hide, urine, etc.) |
47 |
| 424/545 |
Urine |
52 |
| 424/546 |
Sex hormone |
20 |
| 424/69 |
Face or body powders for grooming, adorning, or absorbing |
720 |
| 424/115 |
Fermentate of unknown chemical structure |
300 |
| 424/116 |
Having a known elemental analysis (e.g., antibiotic, etc.) |
106 |
| 424/118 |
45-55% carbon |
123 |
| 424/119 |
Over 55 to 58% carbon |
57 |
| 424/120 |
Over 58 to 60% carbon |
45 |
| 424/121 |
Over 60 to 62% carbon |
62 |
| 424/122 |
Over 62% carbon |
151 |
| 424/117 |
Sulfur containing |
118 |
| 424/123 |
Processes of making, purifying or recovering (nonfermentation) |
69 |
| 424/124 |
Ion exchange or chromatography |
33 |
| 424/DIG.12 |
Fertilization attaching inhibition |
48 |
| 424/DIG.9 |
Fish posts |
6 |
| 424/125 |
Free carbon containing |
49 |
| 424/DIG.3 |
Hair bleach |
44 |
| 424/10.1 |
Identification or warning feature |
8 |
| 424/10.3 |
Color or color change feature |
32 |
| 424/10.31 |
Combined with animal or insect repellant or insecticide (e.g., shark, fish, roach, etc.) |
5 |
| 424/10.32 |
Combined with ophthalmic or dentifrice preparation |
12 |
| 424/10.2 |
Printed or embossed unitary dosage form |
8 |
| 424/10.4 |
Taste or smell or chemical irritation to the eye, nose, or mouth feature |
12 |
| 424/130.1 |
Immunoglobulin, antiserum, antibody, or antibody fragment, except conjugate or complex of the same with nonimmunoglobulin material |
1456 |
| 424/131.1 |
Anti-idiotypic |
129 |
| 424/171.1 |
Binds allergen or component thereof |
13 |
| 424/139.1 |
Binds antigen or epitope whose amino acid sequence is disclosed in whole or in part (e.g., binds specifically-identified amino acid sequence, etc.) |
559 |
| 424/163.1 |
Binds antigens of multiple bacterial species (e.g., multivalent antiserum that binds antigens of multiple bacterial species, etc.) |
45 |
| 424/164.1 |
Binds bacterium or component thereof or substance produced by said bacterium |
190 |
| 424/167.1 |
Clostridium (e.g., clostridium tetani, etc.) |
27 |
| 424/166.1 |
Corynebacterium (e.g., corynebacterium diphtheriae, etc.) |
5 |
| 424/169.1 |
Escherichia |
52 |
| 424/168.1 |
Mycobacterium |
54 |
| 424/170.1 |
Pseudomonas |
29 |
| 424/165.1 |
Staphylococcus or streptococcus (e.g., pneumococcus or streptococcus pneumoniae, streptococcus mutans, etc.) |
109 |
| 424/172.1 |
Binds eukaryotic cell or component thereof or substance produced by said eukaryotic cell (e.g., honey, etc.) |
213 |
| 424/174.1 |
Cancer cell |
185 |
| 424/173.1 |
Hematopoietic cell |
235 |
| 424/138.1 |
Binds expression product or fragment thereof of cancer-related gene (e.g., oncogene, proto-oncogene, etc.) |
269 |
| 424/175.1 |
Binds hapten, hapten-carrier complex, or specifically-identified chemical structure (e.g., drug, etc.) |
51 |
| 424/158.1 |
Binds hormone or other secreted growth regulatory factor, differentiation factor, or intercellular mediator (e.g., cytokine, vascular permeability factor, etc.); or binds serum protein, plasma protein, fibrin, or enzyme |
302 |
| 424/137.1 |
Binds specifically-identified oligosaccharide structure |
141 |
| 424/159.1 |
Binds virus or component thereof |
119 |
| 424/161.1 |
Hepatitis virus |
37 |
| 424/162.1 |
Hog cholera virus |
0 |
| 424/160.1 |
Immunodeficiency virus |
76 |
| 424/132.1 |
Derived from transgenic multicellular eukaryote (e.g., plant, etc.) |
15 |
| 424/157.1 |
Derived from, or present in, food product (e.g., milk, colostrum, whey, eggs, etc.) |
97 |
| 424/140.1 |
Extracorporeal or ex vivo removal of antibodies or immune complexes (e.g., removal of autoantibodies, etc.); or extracorporeal or ex vivo removal of antigen by antibodies (e.g., removal of cancer cells from bone marrow by antibodies, etc.) |
91 |
| 424/176.1 |
Free from infectious agents (e.g., viruses or bacteria removed or inactivated, etc.) |
72 |
| 424/141.1 |
Monoclonal antibody or fragment thereof (i.e., produced by any cloning technology) |
948 |
| 424/150.1 |
Binds bacterium or component thereof or substance produced by said bacterium |
199 |
| 424/146.1 |
Binds enzyme |
90 |
| 424/152.1 |
Binds eukaryotic cell or component thereof or substance produced by said eukaryotic cell |
307 |
| 424/155.1 |
Cancer cell |
360 |
| 424/156.1 |
Antigen characterized by name or molecular weight |
255 |
| 424/153.1 |
Hematopoietic cell |
274 |
| 424/154.1 |
T lymphocytic cell (e.g., t cell, thymocyte, etc.) |
303 |
| 424/145.1 |
Binds hormone or other secreted growth regulatory factor, differentiation factor, or intercellular mediator (e.g., cytokine, etc.); or binds serum protein, plasma protein (e.g., tpa, etc.), or fibrin |
471 |
| 424/151.1 |
Binds parasitic organism (i.e., parasitic protozoan, multicellular ectoparasite (e.g., flea, tick, mite, etc.), or multicellular endoparasite (e.g., parasitic worm, etc.)) or component thereof or substance produced by said parasitic organism |
62 |
| 424/143.1 |
Binds receptor |
619 |
| 424/144.1 |
Receptor integral to or derived from a lymphocytic or lymphocytic-like cell (e.g., nk cell, etc.) |
330 |
| 424/147.1 |
Binds virus or component thereof |
125 |
| 424/149.1 |
Hepatitis virus |
37 |
| 424/148.1 |
Immunodeficiency virus |
66 |
| 424/142.1 |
Human |
276 |
| 424/177.1 |
Reduced antigenicity, reduced ability to bind complement, or reduced numbers of activated complement components (e.g., free from aggregated, denatured, fragmented, or polymerized immunoglobulins; free from proteolytic enzymes, etc.) |
101 |
| 424/133.1 |
Structurally-modified antibody, immunoglobulin, or fragment thereof (e.g., chimeric, humanized, cdr-grafted, mutated, etc.) |
836 |
| 424/134.1 |
Antibody, immunoglobulin, or fragment thereof fused via peptide linkage to nonimmunoglobulin protein, polypeptide, or fragment thereof (i.e., antibody or immunoglobulin fusion protein or polypeptide) |
386 |
| 424/136.1 |
Bispecific or bifunctional, or multispecific or multifunctional, antibody or fragment thereof |
149 |
| 424/135.1 |
Single chain antibody |
210 |
| 424/9.1 |
In vivo diagnosis or in vivo testing |
1205 |
| 424/9.6 |
Diagnostic or test agent produces in vivo fluorescence |
280 |
| 424/9.61 |
Porphyrin or derivative thereof |
107 |
| 424/9.7 |
Diagnostic or test agent produces visible change in mouth |
26 |
| 424/9.71 |
Plaque detection |
16 |
| 424/9.8 |
Diagnostic or test agent produces visible change on skin |
41 |
| 424/9.81 |
Visible immune reaction (e.g., allergy testing, etc.) |
36 |
| 424/9.3 |
Magnetic imaging agent (e.g., nmr, mri, mrs, etc.) |
365 |
| 424/9.35 |
Carbohydrate or derivative thereof attached to or complexed with the agent |
102 |
| 424/9.351 |
The region of the imaging agent responsibile for binding to an in vivo target or the region of the target responsible for binding to the agent is specifically recited functionally or as a sequence of amino acids, carbohydrate residues, or nucleic acids |
12 |
| 424/9.31 |
Clay or zeolite containing |
11 |
| 424/9.37 |
Imageable halogen containing |
74 |
| 424/9.33 |
Nitroxide or nitroxide containing |
37 |
| 424/9.32 |
Particle containing a transition, actinide, or lanthanide metal (e.g., hollow or solid particle, granule, etc.) |
126 |
| 424/9.321 |
Liposome |
134 |
| 424/9.322 |
Polymer containing (e.g., polypeptide, synthetic resin, etc.) |
125 |
| 424/9.323 |
Metal is paramagnetic |
66 |
| 424/9.34 |
Polypeptide attached to or complexed with the agent (e.g., protein, antibody, etc.) |
254 |
| 424/9.341 |
The region of the imaging agent responsible for binding to an in vivo target or the region of the target responsible for binding to the agent is specifically recited functionally or as a sequence of amino acids, carbohydrate residues, or nucleic acids |
69 |
| 424/9.36 |
Transition, actinide, or lanthanide metal containing |
215 |
| 424/9.361 |
Heterocyclic compound is attached to or complexed with the metal |
96 |
| 424/9.363 |
Hetero ring contains at least eight members |
168 |
| 424/9.362 |
Porphyrin or derivative thereof |
77 |
| 424/9.364 |
Polyamino-polycarbonyl moiety attached to or complexed with the metal |
153 |
| 424/9.365 |
Contains at least one -c(=o)-n- group |
95 |
| 424/9.2 |
Testing efficacy or toxicity of a compound or composition (e.g., drug, vaccine, etc.) |
611 |
| 424/9.5 |
Ultrasound contrast agent |
175 |
| 424/9.51 |
Liposome containing |
201 |
| 424/9.52 |
Stable gas bubbles containing or intentional solubilized gas containing |
264 |
| 424/9.4 |
X-ray contrast imaging agent (e.g., computed tomography, angiography, etc.) |
300 |
| 424/9.41 |
Barium containing |
17 |
| 424/9.411 |
Polymer containing (e.g., polypeptide, synthetic resin, etc.) |
43 |
| 424/9.43 |
Carbohydrate or derivative thereof attached to or complexed with the agent |
65 |
| 424/9.45 |
Halogenated benzene ring containing |
136 |
| 424/9.455 |
Carbonyl of a carboxylic acid or salt thereof attached directly to the benzene ring |
41 |
| 424/9.454 |
Three or more amide groups are attached directly to the same benzene ring by nonionic bonding |
62 |
| 424/9.451 |
Two or more halogenated benzene rings in the same compound |
38 |
| 424/9.453 |
Carbonyl of a carboxylic acid or salt thereof attached directly to the benzene ring |
22 |
| 424/9.452 |
Three or more amide groups are attached directly to the same benzene ring by nonionic bonding |
56 |
| 424/9.44 |
Hetero ring containing |
53 |
| 424/9.42 |
Transition, actinide, or lanthanide metal containing |
121 |
| 424/900 |
In vivo diagnostic or in vivo test agent which contains an additional ingredient to reduce the toxicity or side effects of the active ingredient |
30 |
| 424/600 |
Inorganic active ingredient containing |
272 |
| 424/722 |
Alkali metal or alkaline earth containing |
203 |
| 424/677 |
Alkali or alkaline earth chloride (e.g., barium or lithium chloride, etc.) |
|